Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2025-12-27 @ 11:18 PM
Study NCT ID:
NCT06643260
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-04-29
First Post:
2024-10-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy
Sponsor:
Can-Fite BioPharma